Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries 23andMe Holding Co. - Common Stock (NQ: ME ) 3.300 +0.040 (+1.23%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 260,803 Open 3.220 Bid (Size) 3.120 (1) Ask (Size) 3.330 (1) Prev. Close 3.260 Today's Range 3.070 - 3.310 52wk Range 2.655 - 19.34 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News The Shake-Up at Intel December 05, 2024 And cybersecurity consultant Dave Hatter helps us see what's really going on with all of our information. Via The Motley Fool 23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation November 20, 2024 From 23andMe, Inc. Via GlobeNewswire Performance YTD -81.84% -81.84% 1 Month +5.10% +5.10% 3 Month -43.90% -43.90% 6 Month -57.82% -57.82% 1 Year -82.21% -82.21% More News Read More Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs November 12, 2024 Via Benzinga 23andMe Reports Second Quarter Fiscal Year 2025 Financial Results November 12, 2024 From 23andMe, Inc. Via GlobeNewswire Earnings Scheduled For November 12, 2024 November 12, 2024 Via Benzinga Earnings Outlook For 23andMe Holding November 11, 2024 Via Benzinga 23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future November 11, 2024 From 23andMe, Inc. Via GlobeNewswire CORRECTION - 23andMe to Report Q2 FY2025 Financial Results November 07, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe to Report Q2 FY2025 Financial Results November 07, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe Regains Compliance With Nasdaq Listing Requirements October 30, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe Appoints Three New Independent Directors to Board October 29, 2024 From 23andMe, Inc. Via GlobeNewswire ASML's Latest Chapter in the Semiconductor Story October 22, 2024 Via The Motley Fool 23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South October 17, 2024 From 23andMe, Inc. Via GlobeNewswire Author Alok Sama on OpenAI, Bubbles, and When to Sell October 16, 2024 Via The Motley Fool 23andMe Announces Completion of 1-for-20 Reverse Stock Split October 16, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe Announces 1-for-20 Reverse Stock Split October 11, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe Announces Mathew Knowles as New Brand Ambassador October 08, 2024 From 23andMe, Inc. Via GlobeNewswire Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants October 02, 2024 Via Benzinga Topics Data Breach Exposures Information Security 12 Health Care Stocks Moving In Friday's After-Market Session September 27, 2024 Via Benzinga 23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating September 25, 2024 From 23andMe, Inc. Via GlobeNewswire Independent Board Members Of Penny Stock 23andMe Resign, Call Out CEO Anne Wojcicki For Not 'Actionable Proposal' Despite Ample Time September 18, 2024 Via Benzinga General Mills, Steelcase And 3 Stocks To Watch Heading Into Wednesday September 18, 2024 Via Benzinga Independent Directors of 23andMe Resign from Board September 17, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial September 15, 2024 From 23andMe, Inc. Via GlobeNewswire 23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study September 15, 2024 From 23andMe, Inc. Via GlobeNewswire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
